SPRY
ARS Pharmaceuticals, Inc. Common Stock#23 · 2024EPCYearly return
+89%
Peak return
+232%
Max drawdown
-45%
ADR (20 days)
+6.3%
Base
6 days / -25.9%
Prior run
+59%
Breakout volume
5.2x
Pivot
$12.02
Catalyst Relative Staerke/Technik2024-08-07ARS Pharmaceuticals to Participate in the 2024 Wedbush PacGrow Healthcare ConferenceGlobeNewswire Inc.
Kein klarer externer Katalysator in der News-Abdeckung; technische relative Staerke dominiert.
Healthcare · Healthcare & Biotech
Continue in the full Atlas
Drawing, alerts, replay and the live scanner built on the same criteria are part of WickedDesk. Compare SPRY with the current market directly.